This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database.
NIHR HSRIC. Furosemide sc2Wear micro-pump patch for oedema in heart failure. Birmingham: NIHR Horizon Scanning Research&Intelligence Centre. Horizon Scanning Review. 2016
Heart failure is a common and disabling condition that affects the heart's ability to pump blood around the body. The heart muscle doesn't receive enough oxygen to work properly and a blood vessel may completely block off, leading to a heart attack (myocardial infarction), where a section of heart muscle dies completely forming a scar. A sudden worsening of heart failure symptoms can cause fluid to enter the lungs and surrounding tissue.
Furosemide sc2Wear micro-pump patch is intended to treat patients with heart failure who have increased fluid in their lungs and other tissues. This treatment aims to reduce hospital stay for patients who suffer a worsening of their heart failure. The sc2Wear micro-pump delivers the drug just under the skin by a wearable patch, rather than requiring hospital treatment where drugs are given directly into the blood by a drip.
If furosemide sc2Wear micro-pump is licensed for use in the UK, it could be a new treatment option for patients with heart failure and could reduce their hospital stay. Furosemide sc2Wear micro-pump has the potential to reduce symptoms of heart failure and increase survival in this group of patients.
Subject indexing assigned by CRD
Edema; Furosemide; Heart Failure; Humans; Transdermal Patch
Country of organisation
An English language summary is available.
Address for correspondence
NIHR Horizon Scanning Research&Intelligence Centre, University of Birmingham, Institute of Applied Health Research, Public Health building, Edgbaston, Birmingham B15 2TT
Tel: 0121 414 9077 Email: email@example.com
Date abstract record published